CN101959880B - 一种依普罗沙坦甲磺酸盐的制备方法 - Google Patents
一种依普罗沙坦甲磺酸盐的制备方法 Download PDFInfo
- Publication number
- CN101959880B CN101959880B CN2009801078091A CN200980107809A CN101959880B CN 101959880 B CN101959880 B CN 101959880B CN 2009801078091 A CN2009801078091 A CN 2009801078091A CN 200980107809 A CN200980107809 A CN 200980107809A CN 101959880 B CN101959880 B CN 101959880B
- Authority
- CN
- China
- Prior art keywords
- eprosartan
- glacial acetic
- eprosartan mesylate
- acetic acid
- mesylate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009801078091A CN101959880B (zh) | 2008-08-03 | 2009-07-20 | 一种依普罗沙坦甲磺酸盐的制备方法 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200810129646.4 | 2008-08-03 | ||
CNA2008101296464A CN101333216A (zh) | 2008-08-03 | 2008-08-03 | 一种新的依普罗沙坦甲磺酸盐成盐工艺 |
PCT/CN2009/072832 WO2010015169A1 (zh) | 2008-08-03 | 2009-07-20 | 一种依普罗沙甲磺酸盐的制备方法 |
CN2009801078091A CN101959880B (zh) | 2008-08-03 | 2009-07-20 | 一种依普罗沙坦甲磺酸盐的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101959880A CN101959880A (zh) | 2011-01-26 |
CN101959880B true CN101959880B (zh) | 2013-07-17 |
Family
ID=40196129
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2008101296464A Pending CN101333216A (zh) | 2008-08-03 | 2008-08-03 | 一种新的依普罗沙坦甲磺酸盐成盐工艺 |
CN2009801078091A Active CN101959880B (zh) | 2008-08-03 | 2009-07-20 | 一种依普罗沙坦甲磺酸盐的制备方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2008101296464A Pending CN101333216A (zh) | 2008-08-03 | 2008-08-03 | 一种新的依普罗沙坦甲磺酸盐成盐工艺 |
Country Status (4)
Country | Link |
---|---|
US (1) | US8546585B2 (zh) |
EP (1) | EP2305670A4 (zh) |
CN (2) | CN101333216A (zh) |
WO (1) | WO2010015169A1 (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5185351A (en) * | 1989-06-14 | 1993-02-09 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists |
WO1997036874A1 (en) * | 1996-03-29 | 1997-10-09 | Smithkline Beecham Corporation | Eprosartan dihydrate and a process for its production and formulation |
WO2008078330A1 (en) * | 2006-12-27 | 2008-07-03 | Hetero Drugs Limited | Improved process for eprosartan |
WO2009084028A2 (en) * | 2007-12-03 | 2009-07-09 | Neuland Laboratories Ltd | Improved process for manufacturing anhydrous (e)-3-[2-butyl-1- {(4-carboxyphenyl) methyl}-1h-imidazole-5-yl]-(thiophen-2- ylmethyl)prop-2-enoic acid methane sulfonate |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009013760A2 (en) * | 2007-07-25 | 2009-01-29 | Hetero Drugs Limited | Eprosartan mesylate crystalline particles and a process for preparing pure eprosartan |
-
2008
- 2008-08-03 CN CNA2008101296464A patent/CN101333216A/zh active Pending
-
2009
- 2009-07-20 WO PCT/CN2009/072832 patent/WO2010015169A1/zh active Application Filing
- 2009-07-20 EP EP09804469A patent/EP2305670A4/en not_active Ceased
- 2009-07-20 CN CN2009801078091A patent/CN101959880B/zh active Active
- 2009-07-20 US US12/989,765 patent/US8546585B2/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5185351A (en) * | 1989-06-14 | 1993-02-09 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists |
WO1997036874A1 (en) * | 1996-03-29 | 1997-10-09 | Smithkline Beecham Corporation | Eprosartan dihydrate and a process for its production and formulation |
WO2008078330A1 (en) * | 2006-12-27 | 2008-07-03 | Hetero Drugs Limited | Improved process for eprosartan |
WO2009084028A2 (en) * | 2007-12-03 | 2009-07-09 | Neuland Laboratories Ltd | Improved process for manufacturing anhydrous (e)-3-[2-butyl-1- {(4-carboxyphenyl) methyl}-1h-imidazole-5-yl]-(thiophen-2- ylmethyl)prop-2-enoic acid methane sulfonate |
Also Published As
Publication number | Publication date |
---|---|
CN101333216A (zh) | 2008-12-31 |
WO2010015169A1 (zh) | 2010-02-11 |
US20110046391A1 (en) | 2011-02-24 |
US8546585B2 (en) | 2013-10-01 |
EP2305670A4 (en) | 2011-09-14 |
CN101959880A (zh) | 2011-01-26 |
EP2305670A1 (en) | 2011-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20150068483A (ko) | 닐로티닙 및 선택된 공-결정 형성제를 포함하는 다성분 결정질 시스템 | |
CN101983195A (zh) | 新型多晶型物及其制备方法 | |
CN102491918B (zh) | 一种丙氨酰谷氨酰胺化合物及其制法 | |
WO2011086541A1 (en) | Novel polymorph of nilotinib monohydrochloride monohydrate | |
CN102190657A (zh) | 莫西沙星及其盐的制备方法 | |
CN101348463A (zh) | 阿加曲班及其中间体的合成方法 | |
US9018389B2 (en) | Process for the preparation of Deferasirox | |
CN101959880B (zh) | 一种依普罗沙坦甲磺酸盐的制备方法 | |
CN102846609B (zh) | 抗高血压药物伊拉地平的合成及其制剂 | |
CN102267961A (zh) | 制备(3r,4r,5s)-4,5-环氧基-3-(1-乙基丙氧基)-1-环己烯-1-甲酸乙酯的方法 | |
CN107652271B (zh) | 一种托匹司他晶型i的制备方法 | |
CN103113408B (zh) | 一种制备磷霉素左磷右胺盐的新方法 | |
CN111548310B (zh) | 一种左西孟旦钠晶型及其制备方法 | |
CN101735239A (zh) | 一种无水奥氮平晶型ii的制备方法 | |
CN104418810A (zh) | 一种左西孟旦的合成新路线 | |
CN108250183A (zh) | 一种高纯度的托匹司他的制备方法 | |
CN103373956A (zh) | 一种制备丁酸氯维地平的方法 | |
CN107759609A (zh) | 一种阿塞那平的纯化方法 | |
CN102197034A (zh) | 舒尼替尼的新型多晶型物及其制备方法 | |
CN109280050B (zh) | 一种医药化合物阿伐那非的制备方法 | |
CN104558103B (zh) | 一种阿加曲班中间体的制备方法 | |
CN109942453A (zh) | 一种缬沙坦的新杂质以及合成方法 | |
CN109280049B (zh) | 一种医药化合物阿伐那非的合成方法 | |
WO2017029584A1 (en) | Amorphous form of bosutinib | |
CN106187886B (zh) | 一种制备高纯度伯舒替尼一水合物的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY Effective date: 20131114 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20131114 Address after: 317000 No. 1 Bridge Road, Zhejiang, China Patentee after: Zhejiang Huahai Pharmaceutical Co., Ltd. Patentee after: Shanghai Institute of pharmaceutical industry Address before: 317000 No. 1 Bridge Road, Zhejiang, China Patentee before: Zhejiang Huahai Pharmaceutical Co., Ltd. |
|
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Shi Huilin Inventor after: Huang Xiangliang Inventor before: Huang Xiangliang |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: HUANG XIANGLIANG TO: SHI HUILIN HUANG XIANGLIANG |
|
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY Effective date: 20150609 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Huang Xiangliang Inventor before: Shi Huilin Inventor before: Huang Xiangliang |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150609 Address after: 317024 No. 1 Xun Qiao Road, Linhai City, Zhejiang, China Patentee after: Zhejiang Huahai Pharmaceutical Co., Ltd. Address before: 317024 No. 1 Xun Qiao Road, Linhai City, Zhejiang, China Patentee before: Zhejiang Huahai Pharmaceutical Co., Ltd. Patentee before: Shanghai Institute of pharmaceutical industry |